Cancer Screenings Continue Years After Guidelines Change to Limit Unnecessary Tests
It can take over a decade for unnecessary cancer screenings to significantly decline after updated guidelines advise against them.
Read MorePosted by Chris Wolski | Jun 10, 2025 | Cancer |
It can take over a decade for unnecessary cancer screenings to significantly decline after updated guidelines advise against them.
Read MorePosted by Chris Wolski | Jun 10, 2025 | Molecular Diagnostics |
Researchers have developed a blood-based Healthspan Proteomic Score (HPS) that predicts biological aging and risk of chronic diseases.
Read MorePosted by Chris Wolski | Jun 5, 2025 | Colorectal |
A study found that colorectal cancer screening could be boosted by using a rapid, accurate app-read smartphone FIT.
Read MorePosted by Chris Wolski | Jun 4, 2025 | Quality Systems |
Revvity has launched three FDA-compliant Mimix reference standards for IVD use, aimed at enhancing NGS and ddPCR assays.
Read MorePosted by Chris Wolski | Jun 3, 2025 | Breast |
Personalis, Inc. unveiled promising new clinical data from the PREDICT DNA and SCANDARE studies at ASCO 2025.
Read More